Structure Database (LMSD)

Back

LMSD: Lipid classification search results

Fatty Acyls [FA]

LM_ID Common Name Systematic Name Species Shorthand Formula Mass
LMFA07010641 3Z-Hexenyl 2R-hydroxy-3-methylbutyrate 3Z-Hexenyl 2R-hydroxy-3-methylbutyrate WE 11:1;O C11H20O3 200.141245
LMFA07010641 3Z-Hexenyl 2R-hydroxy-3-methylbutyrate 3Z-Hexenyl 2R-hydroxy-3-methylbutyrate WE 11:1;O C11H20O3 200.141245
LMFA07010641 3Z-Hexenyl 2R-hydroxy-3-methylbutyrate 3Z-Hexenyl 2R-hydroxy-3-methylbutyrate WE 11:1;O C11H20O3 200.141245
LMFA07010510 WE 18:0/4:0(2Me) octadecyl 2-methyl-butanoate WE 23:0 C23H46O2 354.349781
LMFA07010510 WE 18:0/4:0(2Me) octadecyl 2-methyl-butanoate WE 23:0 C23H46O2 354.349781
LMFA03110143 ent-8-epi-5-F2c-IsoP 5R,9R,11S-trihydroxy-6E,14Z-prostadienoic acid-cyclo[8R,12R] FA 20:3;O3 C20H34O5 354.240626
LMFA07010037 Lauryl stearate dodecanyl octadecanoate WE 30:0 C30H60O2 452.459331
LMFA08020406 N-lignoceroyl-O-phosphocholineserine N-tetracosanoyl-O-phosphocholine-L-serine C32H65N2O7P 620.452939
LMFA08020401 N-palmitoyl-O-phosphocholineserine N-hexadecanoyl-O-phosphocholine-L-serine C24H49N2O7P 508.327739
LMFA08020405 N-behenoyl-O-phosphocholineserine N-docosanoyl-O-phosphocholine-L-serine C30H61N2O7P 592.421639
LMFA08020404 N-arachidoyl-O-phosphocholineserine N-eicosanoyl-O-phosphocholine-L-serine C28H57N2O7P 564.390339
LMFA08020403 N-stearoyl-O-phosphocholineserine N-octadecanoyl-O-phosphocholine-L-serine C26H53N2O7P 536.359039
LMFA07010628 WE 8:2(2Z,6E)(3Me,7Me)/8:0 (Z)-3,7-Dimethyl-2,6-octadienyl octanoate WE 18:2 C18H32O2 280.240231
LMFA07010604 WE 8:1(2E)/4:1(2E)(2Me) (E)-2-Octenyl 2-methyl-(E)-2-butenoate WE 13:2 C13H22O2 210.161980
LMFA07010604 WE 8:1(2E)/4:1(2E)(2Me) (E)-2-Octenyl 2-methyl-(E)-2-butenoate WE 13:2 C13H22O2 210.161980
LMFA07010604 WE 8:1(2E)/4:1(2E)(2Me) (E)-2-Octenyl 2-methyl-(E)-2-butenoate WE 13:2 C13H22O2 210.161980
LMFA07010637 WE 4:1(3E)(3Me)/20:0 3-Methyl-3-butenyl eicosanoate WE 25:1 C25H48O2 380.365431
LMFA07010637 WE 4:1(3E)(3Me)/20:0 3-Methyl-3-butenyl eicosanoate WE 25:1 C25H48O2 380.365431
LMFA07010637 WE 4:1(3E)(3Me)/20:0 3-Methyl-3-butenyl eicosanoate WE 25:1 C25H48O2 380.365431
LMFA07010592 WE 6:1(3Z)/4:0(3Me) (Z)-3-Hexenyl 3-methylbutanoate WE 11:1 C11H20O2 184.146330
LMFA07010592 WE 6:1(3Z)/4:0(3Me) (Z)-3-Hexenyl 3-methylbutanoate WE 11:1 C11H20O2 184.146330
LMFA07010592 WE 6:1(3Z)/4:0(3Me) (Z)-3-Hexenyl 3-methylbutanoate WE 11:1 C11H20O2 184.146330
LMFA07010484 WE 12:0/12:0(10Me) dodecyl 10-methyl-dodecanoate WE 25:0 C25H50O2 382.381081
LMFA07010484 WE 12:0/12:0(10Me) dodecyl 10-methyl-dodecanoate WE 25:0 C25H50O2 382.381081
LMFA07010531 WE 10:1(3Z)/6:1(3E) (Z)-3-Decenyl (E)-3-hexenoate WE 16:2 C16H28O2 252.208930
LMFA07010531 WE 10:1(3Z)/6:1(3E) (Z)-3-Decenyl (E)-3-hexenoate WE 16:2 C16H28O2 252.208930
LMFA07010625 WE 8:2(2Z,6E)(3Me,7Me)/4:0(3Me) (Z)-3,7-Dimethyl-2,6-octadienyl 3-methylbutanoate WE 15:2 C15H26O2 238.193280
LMFA04000033 (+/-)-20-HDoHE (+/-)-20-hydroxy-4Z,7Z,10Z,13Z,16Z,18E-docosahexaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000033 (+/-)-20-HDoHE (+/-)-20-hydroxy-4Z,7Z,10Z,13Z,16Z,18E-docosahexaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000033 (+/-)-20-HDoHE (+/-)-20-hydroxy-4Z,7Z,10Z,13Z,16Z,18E-docosahexaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000037 16(17)-EpDPE (+/-)-16(17)-epoxy-4Z,7Z,10Z,13Z,19Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000037 16(17)-EpDPE (+/-)-16(17)-epoxy-4Z,7Z,10Z,13Z,19Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000037 16(17)-EpDPE (+/-)-16(17)-epoxy-4Z,7Z,10Z,13Z,19Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000038 19(20)-EpDPE (+/-)-19(20)-epoxy-4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000038 19(20)-EpDPE (+/-)-19(20)-epoxy-4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000038 19(20)-EpDPE (+/-)-19(20)-epoxy-4Z,7Z,10Z,13Z,16Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000042 16,17-DiHDPE (+/-)-16,17-dihydroxy-4Z,7Z,10Z,13Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245711
LMFA04000042 16,17-DiHDPE (+/-)-16,17-dihydroxy-4Z,7Z,10Z,13Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245711
LMFA04000042 16,17-DiHDPE (+/-)-16,17-dihydroxy-4Z,7Z,10Z,13Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245711
LMFA04000034 7(8)-EpDPE (+/-)-7(8)-epoxy-4Z,10Z,13Z,16Z,19Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000034 7(8)-EpDPE (+/-)-7(8)-epoxy-4Z,10Z,13Z,16Z,19Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000034 7(8)-EpDPE (+/-)-7(8)-epoxy-4Z,10Z,13Z,16Z,19Z-docosapentaenoic acid FA 22:6;O C22H32O3 344.235146
LMFA04000039 7,8-DiHDPE (+/-)-7,8-dihydroxy-4Z,10Z,13Z,16Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245711
LMFA04000039 7,8-DiHDPE (+/-)-7,8-dihydroxy-4Z,10Z,13Z,16Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245711
LMFA04000039 7,8-DiHDPE (+/-)-7,8-dihydroxy-4Z,10Z,13Z,16Z,19Z-docosapentaenoic acid FA 22:5;O2 C22H34O4 362.245711
LMFA07040205 Gliomasolide D 4R,5S,7R-trihydroxy-2E-octadecen-13R-olide FA 18:2;O3 C18H32O5 328.224976
LMFA07010535 (Z)-7-Dodecenyl formate (Z)-7-Dodecenyl formate SFE 13:1 C13H24O2 212.177630
LMFA07010535 (Z)-7-Dodecenyl formate (Z)-7-Dodecenyl formate SFE 13:1 C13H24O2 212.177630
LMFA11000278 14-Methyltriacontane 14-Methyltriacontane C31H64 436.500801
LMFA07010092 Palmitoleyl laurate 9Z-hexadecenyl dodecanoate WE 28:1 C28H54O2 422.412381